02 November 2020 | News
VIRULINA is a preclinically and clinically tested product which has been validated as an effective adjunct remedy for the prevention of ARDS caused due to COVID-19 infection
Image Credit: newsvoir
Chitkara University, Chitkara College of Pharmacy (CCP), Rajpura, Punjab in collaboration with Natural Solutions, Mumbai organised an e-conference on the theme ‘Management of Acute Respiratory Distress Syndrome (ARDS) & Co-morbidities in COVID-19 & related infections’ (MARDS-CVD-19) on October 31, 2020.
The event also marked the product launch of a preclinically and clinically tested product ‘VIRULINA’, which has been validated as an effective adjunct remedy for the prevention of ARDS caused due to COVID-19 infection.
The conference included technical sessions and panel discussion on contemporary and relevant topics like COVID-19: Epidemiology and Morbidities, Mainstay Clinical Management, Supportive Therapies & Success, Phytopharmaceuticals, Alternative Therapies, Surgical interventions in co-morbidities, Vaccines, and mass Vaccination strategy, and Clinical Pathology Updates.
Dr Anil Sharma, MD, Natural Solutions, while introducing the product shared that, “VIRULINA is a polyherbal combination. A powerful immune-stimulant which is clinically-tested. As per the studies conducted, it has been clinically proven that it helps in the prevention of life-threatening symptoms such as Acute Respiratory Distress Syndrome (ARDS) caused due to COVID-19 infection.
Dr Madhu Chitkara, Pro-Chancellor, Chitkara University while inaugurating the e-conference congratulated the team of Natural Solutions (Mumbai), and the Chitkara College of Pharmacy (CCP) and shared, “The e-conference and the technical collaboration with Natural Solutions to develop a remedy for helping COVID-19 patients is a testimony of what Chitkara University stands for - collaborating and creating knowledge for the greater good of the humankind. The College of Pharmacy at Chitkara University has always valued its collaboration with pharma and clinical research leaders like Fortis, Clinsync, Parexel. We are proud and grateful for our collaboration with Natural Solutions for clinical trials and the development of new-age & research-based Phytopharmaceuticals.”
The event was attended by academicians, experts, and students from across the country.